Trial intelligence / Profile preview

Venlafaxine and pregabalin effects on CO2-induced anxiety

2008-000971-15Phase 4Completed

Sponsor
University of Bristol
Start
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of venlafaxine and pregabalin in generalized anxiety disorder (GAD) (2 arms), sponsored by University of Bristol. Primary endpoint: Reduction in anxiety symptoms. Started Apr 2008; status: completed.

02

Drugs

venlafaxinepregabalin
03

Conditions

generalized anxiety disorder (GAD)

Beyond the preview

Go deeper on 2008-000971-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000971-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call